Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 3/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.36 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.35 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.35 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 5/20 | 0.33 |
| ▸ | RAB9A | P51151 | 5/20 | 0.33 |
| ▸ | HTT | P42858 | 4/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.33 |
| ▸ | GALR3 | O60755 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3876682 | 1.00 | PTGS1 (0.36) | PTGS1PTGS2MGLLFAAHGNAI3 | |
| SCHEMBL9905548 | 0.86 | PTGS1 (0.37) | PTGS1PTGS2MGLLFAAHTSHR | |
| SCHEMBL16341438 | 0.72 | TSHR (0.34) | TSHR | |
| SCHEMBL4270831 | 0.66 | TSHR (0.47) | PTGS1PTGS2MGLLFAAHTSHR | |
| SCHEMBL4274617 | 0.66 | TSHR (0.47) | PTGS1PTGS2MGLLFAAHTSHR | |
| SCHEMBL4270037 | 0.66 | TSHR (0.47) | PTGS1PTGS2MGLLFAAHTSHR | |
| SCHEMBL18838747 | 0.63 | NPC1 (0.44) | PTGS1PTGS2MGLLFAAHTSHR | |
| Hexadecane SCHEMBL7035543 | 0.59 | TSHR (0.80) | TSHRTHRBDNM1LMNAMEN1 | |
| Decane SCHEMBL17434820 | 0.59 | TSHR (0.80) | TSHRTHRBDNM1LMNAMEN1 | |
| Tetradecane SCHEMBL23924271 | 0.59 | TSHR (1.00) | TSHRTHRBDNM1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117580799-A | Hydrogen storage based on aqueous formate-bicarbonate (bicarbonate) balance | 乔迈斯计划有限责任公司 | 2024-02-20 | — | — | CN | claimed |
| CN-117580799-A | Hydrogen storage based on aqueous formate-bicarbonate (bicarbonate) balance | 乔迈斯计划有限责任公司 | 2024-02-20 | — | — | CN | disclosed |
| US-7501522-B2 | Method for the production of purified 1,3-substituted imidazolium salts | BASF AKTIENGESELLSCHAFT (DE) | 2009-03-10 | — | — | US | disclosed |
| EP-1651614-B1 | METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS | BASF AG (DE) | 2007-07-11 | — | — | EP | disclosed |
| US-20060149074-A1 | Method for the production of purified 1,3-substituted imidazolium salts | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-06 | — | — | US | disclosed |
| EP-1651614-A1 | METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005019183-A1 | METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060149074-A1 | Method for the production of purified 1,3-substituted imidazolium salts | HIRA, HAO2, HACL2 | PTGS1 210/4885PTGS2 289/4885MGLL 3876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.